Patients are searching for this trial right now

This page is already ranking on Google. Activate it to start receiving pre-qualified patient leads directly in your inbox.

14-day free trial · $44/mo after · Cancel anytime · Money-back guarantee

NCT06087224 · Mayo Clinic

The TELENEO Trial: A Multicenter Trial of Telemedicine for Advanced Neonatal Resuscitations in Community Hospitals

What this study is about

The purpose of this study is to evaluate the impact of real-time audio-video telemedicine consults with a neonatologist (termed teleneonatology) on the early health outcomes of at-risk neonates delivered in community hospitals.

View original scientific description

The purpose of this study is to evaluate the impact of real-time audio-video telemedicine consults with a neonatologist (termed teleneonatology) on the early health outcomes of at-risk neonates delivered in community hospitals.

Who can participate

This study lists these criteria on ClinicalTrials.gov. A study coordinator reviews eligibility during screening — this page does not determine whether you qualify.

Inclusion criteria

  • GROUP 1: Community hospital clinicians To be eligible to participate in this study, an individual must meet all of the following criteria:
  • A clinician who attends newborn resuscitations at a participating community hospital spoke site.
  • Provision of informed oral consent prior to any mandatory study specific procedures and analyses. GROUP 2: At-risk outborn neonates To be eligible for this study, a neonate born in a participating community hospital spoke site must meet \*at least one\
  • of the following inclusion criteria
  • Preterm birth at less than 32 weeks' gestation at delivery; OR
  • Need for advanced resuscitation defined as:
  • positive pressure ventilation (PPV) initiated soon after birth and continued for at least 10 minutes; OR
  • placement of an alternative airway (endotracheal tube or laryngeal mask) to provide PPV; OR
  • chest compressions.

Exclusion criteria

  • GROUP 1: Community hospital clinicians None GROUP 2: At-risk outborn neonates A neonate born in a participating community hospital spoke site who meets any of the following criteria will be excluded from the study:
  • Birth outside of the hospital birthing center.
  • Neonatal transport team present at time of birth and providing resuscitative care.
  • Severe congenital anomaly necessitating intensive care or surgery in the first two weeks of life.
  • Plan for comfort care (non-resuscitation) following delivery.
  • In-person neonatology-trained physician present for the resuscitation.

Where

  • Anchorage, Alaska
  • Juneau, Alaska
  • Ketchikan, Alaska
  • Pheonix, Arizona
  • Rochester, Minnesota
  • Ada, Oklahoma
  • Altus, Oklahoma
  • Elk City, Oklahoma
  • Oklahoma City, Oklahoma
  • Anacortes, Washington
  • Everett, Washington
  • Port Angeles, Washington

And 8 more locations — see the full list below.

Frequently asked questions

What is a clinical trial?

A clinical trial is a research study that tests new medical treatments, drugs, devices, or procedures to determine their safety and effectiveness. Trials are carefully designed and monitored to protect participants while advancing medical knowledge.

Is it safe to participate?

Clinical trials follow strict safety guidelines and ethical standards. Trials must be reviewed and approved, and participants are closely monitored by medical professionals throughout the study. You can withdraw at any time if you choose.

Will I be compensated?

Many clinical trials offer compensation for your time, travel expenses, and inconvenience. The specific compensation varies by study and will be discussed during the screening process. All study-related medical care is typically provided at no cost to participants.

Will I receive a placebo instead of treatment?

When effective treatment exists, participants typically receive either the standard treatment plus the study intervention, or the standard treatment plus placebo. You would not be denied effective care. Placebos are primarily used when no proven treatment is available, or in addition to standard care. Your trial consent form will clearly explain what treatments you may receive.

Can I leave a trial if I change my mind?

Absolutely. Participation in clinical trials is completely voluntary. You have the right to withdraw from the study at any time, for any reason, without penalty or loss of benefits to which you are otherwise entitled.

How long does a clinical trial last?

Trial duration varies widely depending on the study design and purpose. Some trials last just a few weeks, while others may continue for months or years. The study coordinator will provide specific timeline information during your screening call.

Data: ClinicalTrials.gov · synced Nov 21, 2025 · Source of record for eligibility and locations

📊
1 of 947 participants interested
0% interest

See if this study fits

A short prescreen based on this study's listed criteria. A coordinator confirms eligibility — this is not a medical assessment.

Preparing your pre-screening questions…

Study locations

Choose your preferred location, or select flexible during enrollment.

RECRUITING

Anchorage

Alaska

Location available
RECRUITING

Juneau

Alaska

Location available
RECRUITING

Ketchikan

Alaska

Location available
ACTIVE_NOT_RECRUITING

Pheonix

Arizona

Location available
ACTIVE_NOT_RECRUITING

Rochester

Minnesota

Location available
RECRUITING

Ada

Oklahoma

Location available
View Ada location page
RECRUITING

Altus

Oklahoma

Location available
View Altus location page
RECRUITING

Elk City

Oklahoma

Location available
RECRUITING

Oklahoma City

Oklahoma

Location available

And 12 more locations available.

Express your interest

Share your contact details and a study coordinator can follow up about screening.

Secure & Confidential

Your information is protected and will only be shared with the research team.

What participation can include

  • Study-related care provided by the research team
  • Close monitoring by medical professionals
  • Possible compensation for time and travel*
  • The option to withdraw at any time
  • Contributing to medical research that may help future patients

*Compensation varies by study. Confirm details with coordinator.

Typical next steps

  1. 1.Submit this form
  2. 2.Phone screening
  3. 3.In-person assessment if eligible
  4. 4.Begin participation

Find More Premature Birth Trials by City

Browse all premature birth clinical trials in these cities — not just this study.

Browse More Trials by Condition

Looking for Death; Neonatal Treatment in Anchorage?

Join others in Alaska exploring innovative treatment options through clinical research

Death; Neonatal Treatment Options in Anchorage, Alaska

If you're searching for Death; Neonatal treatment in Anchorage, participating in a clinical research study may provide access to innovative approaches under expert medical supervision. This study is actively recruiting participants in Anchorage, Juneau, Ketchikan and surrounding areas.

Clinical trials offer participants the opportunity to receive cutting-edge treatments while contributing to medical research that may help future patients with Death; Neonatal. All study-related care is provided at no cost to participants.

Local Sites
3 locations in Alaska
Now Enrolling
Up to 947 participants
Quick Start
Screening available now

Why Consider a Clinical Trial for Death; Neonatal?

Potential Benefits

  • Access to new treatment approaches before public availability
  • Close monitoring by experienced medical professionals
  • Study-related care provided at no cost
  • Contribute to medical research for Death; Neonatal

What to Expect

  • Initial screening to determine eligibility
  • Regular check-ups and monitoring visits
  • Possible compensation for time and travel
  • You can withdraw at any time

Frequently Asked Questions About This Death; Neonatal Study

Important Clinical Trial Information

This information is provided for educational purposes and does not constitute medical advice. Clinical trial participation involves potential risks and benefits. Eligibility requirements apply and will be assessed during the screening process.

Study identifier: NCT06087224. For complete study details, visit ClinicalTrials.gov. Always consult with your healthcare provider before making decisions about your medical care or participating in clinical research.